vs
Astrana Health, Inc.（ASTH）与MSC INDUSTRIAL DIRECT CO INC（MSM）财务数据对比。点击上方公司名可切换其他公司
MSC INDUSTRIAL DIRECT CO INC的季度营收约是Astrana Health, Inc.的1.0倍（$965.7M vs $950.5M），MSC INDUSTRIAL DIRECT CO INC净利率更高（5.4% vs 0.7%，领先4.7%），Astrana Health, Inc.同比增速更快（42.9% vs 4.0%），MSC INDUSTRIAL DIRECT CO INC自由现金流更多（$7.4M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -3.4%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
MSC工业直销公司（MSC）通过旗下主要子公司MSC工业供应公司，是美国规模最大的工业设备分销商之一，可提供超过150万种金属加工及其他工业类产品，广泛服务于工业制造、维修运维等领域的客户需求。
ASTH vs MSM — 直观对比
营收规模更大
MSM
是对方的1.0倍
$950.5M
营收增速更快
ASTH
高出38.9%
4.0%
净利率更高
MSM
高出4.7%
0.7%
自由现金流更多
MSM
多$13.4M
$-6.0M
两年增速更快
ASTH
近两年复合增速
-3.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $965.7M |
| 净利润 | $6.6M | $51.8M |
| 毛利率 | — | 40.7% |
| 营业利润率 | 1.9% | 7.9% |
| 净利率 | 0.7% | 5.4% |
| 营收同比 | 42.9% | 4.0% |
| 净利润同比 | 184.4% | 11.1% |
| 每股收益（稀释后） | $0.12 | $0.93 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHMSM
| Q4 25 | $950.5M | $965.7M | ||
| Q3 25 | $956.0M | $978.2M | ||
| Q2 25 | $654.8M | $971.1M | ||
| Q1 25 | $620.4M | — | ||
| Q4 24 | $665.2M | $928.5M | ||
| Q3 24 | $478.7M | — | ||
| Q2 24 | $486.3M | $979.4M | ||
| Q1 24 | $404.4M | $935.3M |
净利润ASTHMSM
| Q4 25 | $6.6M | $51.8M | ||
| Q3 25 | $373.0K | $56.5M | ||
| Q2 25 | $9.4M | $56.8M | ||
| Q1 25 | $6.7M | — | ||
| Q4 24 | $-7.8M | $46.6M | ||
| Q3 24 | $16.1M | — | ||
| Q2 24 | $19.2M | $71.7M | ||
| Q1 24 | $14.8M | $61.8M |
毛利率ASTHMSM
| Q4 25 | — | 40.7% | ||
| Q3 25 | — | 40.4% | ||
| Q2 25 | — | 41.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 40.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 40.9% | ||
| Q1 24 | — | 41.5% |
营业利润率ASTHMSM
| Q4 25 | 1.9% | 7.9% | ||
| Q3 25 | 2.0% | 8.6% | ||
| Q2 25 | 3.1% | 8.5% | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 0.1% | 7.8% | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 6.2% | 10.9% | ||
| Q1 24 | 7.5% | 9.7% |
净利率ASTHMSM
| Q4 25 | 0.7% | 5.4% | ||
| Q3 25 | 0.0% | 5.8% | ||
| Q2 25 | 1.4% | 5.9% | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | -1.2% | 5.0% | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 3.9% | 7.3% | ||
| Q1 24 | 3.7% | 6.6% |
每股收益（稀释后）ASTHMSM
| Q4 25 | $0.12 | $0.93 | ||
| Q3 25 | $0.01 | $1.02 | ||
| Q2 25 | $0.19 | $1.02 | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $-0.14 | $0.83 | ||
| Q3 24 | $0.33 | — | ||
| Q2 24 | $0.40 | $1.27 | ||
| Q1 24 | $0.31 | $1.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $40.3M |
| 总债务越低越好 | — | $214.1M |
| 股东权益账面价值 | $779.3M | $1.4B |
| 总资产 | $2.2B | $2.5B |
| 负债/权益比越低杠杆越低 | — | 0.16× |
8季度趋势，按日历期对齐
现金及短期投资ASTHMSM
| Q4 25 | $429.5M | $40.3M | ||
| Q3 25 | $463.4M | $56.2M | ||
| Q2 25 | $342.1M | $71.7M | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | $57.3M | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | $25.9M | ||
| Q1 24 | $337.3M | $22.2M |
总债务ASTHMSM
| Q4 25 | — | $214.1M | ||
| Q3 25 | — | $168.8M | ||
| Q2 25 | — | $285.0M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $289.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $299.8M | ||
| Q1 24 | — | $294.5M |
股东权益ASTHMSM
| Q4 25 | $779.3M | $1.4B | ||
| Q3 25 | $775.5M | $1.4B | ||
| Q2 25 | $765.5M | $1.4B | ||
| Q1 25 | $745.4M | — | ||
| Q4 24 | $712.7M | $1.4B | ||
| Q3 24 | $704.6M | — | ||
| Q2 24 | $678.9M | $1.4B | ||
| Q1 24 | $653.5M | $1.4B |
总资产ASTHMSM
| Q4 25 | $2.2B | $2.5B | ||
| Q3 25 | $2.2B | $2.5B | ||
| Q2 25 | $1.4B | $2.5B | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | $2.5B | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | $2.5B | ||
| Q1 24 | $1.2B | $2.5B |
负债/权益比ASTHMSM
| Q4 25 | — | 0.16× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.21× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $29.4M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $7.4M |
| 自由现金流率自由现金流/营收 | -0.6% | 0.8% |
| 资本支出强度资本支出/营收 | 0.3% | 2.3% |
| 现金转化率经营现金流/净利润 | -0.44× | 0.57× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHMSM
| Q4 25 | $-2.9M | $29.4M | ||
| Q3 25 | $10.0M | — | ||
| Q2 25 | $90.9M | $151.6M | ||
| Q1 25 | $16.6M | — | ||
| Q4 24 | $-10.9M | $101.9M | ||
| Q3 24 | $34.0M | — | ||
| Q2 24 | $23.2M | $143.5M | ||
| Q1 24 | $6.0M | $78.7M |
自由现金流ASTHMSM
| Q4 25 | $-6.0M | $7.4M | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | $100.7M | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | $81.7M | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | $114.0M | ||
| Q1 24 | $5.6M | $53.4M |
自由现金流率ASTHMSM
| Q4 25 | -0.6% | 0.8% | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | 10.4% | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | 8.8% | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | 11.6% | ||
| Q1 24 | 1.4% | 5.7% |
资本支出强度ASTHMSM
| Q4 25 | 0.3% | 2.3% | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | 5.2% | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | 2.2% | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | 3.0% | ||
| Q1 24 | 0.1% | 2.7% |
现金转化率ASTHMSM
| Q4 25 | -0.44× | 0.57× | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | 2.67× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | 2.18× | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | 2.00× | ||
| Q1 24 | 0.40× | 1.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
MSM
暂无分部数据
